Search Results 641-650 of 16912 for Keratolytic

  1. Intraoperative radiation therapy (IORT) - Doctors & Departments - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a Comprehensive Cancer Center. This designation ...

  2. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    This rare type of cancer can begin in the muscles, fat, blood vessels, nerves, tendons and the lining of joints. Treatment usually includes surgery.

  3. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    This rare type of cancer can begin in the muscles, fat, blood vessels, nerves, tendons and the lining of joints. Treatment usually includes surgery.

  4. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    This rare type of cancer can begin in the muscles, fat, blood vessels, nerves, tendons and the lining of joints. Treatment usually includes surgery.

  5. Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

    The aim of PERKA-812-003 study is to investigate the safety, pharmacokinetics and preliminary anti-tumor activity of treatment with NMS-03597812 as single agent ...

  6. chest pain Archives - Mayo Clinic News Network

  7. Oncology (Medical) - Clinical trials

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  8. Confirmatory Study Of NeoCart In Knee Cartilage Repair - Mayo Clinic

    This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the ...

  9. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  10. A Study to Compare Subcutaneous Daratumumab with Intravenous Daratumumab - Mayo Clinic

    The purpose of this study is to evaluate qualtiy of life (QOL) metrics while receiving subcutaneous (SQ) daratumumab, patient satisfaction, and patient ...